About the Journal
Aims and scope
Vascular Cell represents an open access medical journal which focuses on publication of a wide range of topics related to endothelial “vascular cell” and system physiopathology including neovascularization and angiogenesis. As the field of vascular research is continuously expanding, thorough high impact data reported by developmental, experimental and clinical studies we believe that “vascular cell” represents a crucial factor in numerous pathological settings such as: cancer, stroke, myocardial infarction or atherosclerosis. Therefore, an efficient manipulation of angiogenesis and vascular cell is of paramount importance for the clinical outcome in numerous diseases.
In this context, Vascular Cell selects for publication the best experimental studies as well as clinical trials and case reports. In addition, our journal publishes innovative protocols and methods related to vascular and angiogenesis research. We are particularly interested in studies focusing on elucidation of molecular mechanisms of vascular development in various pathological settings as well as in vivo imaging studies and clinical trials with factors modulating angiogenesis. Also, since angiogenesis represents a key player modulating tissue regeneration and 3D biological manufacturing, our journal is accepting high quality manuscripts reporting innovative research focusing on these fields. On a special note, Vascular Cell will particularly encourage the publication of inter- and trans-disciplinary studies that combine experimental with animal and clinical studies validating concepts or hypotheses related to “vascular cell” behaviour or angiogenesis. Moreover, our journal offers a permanent sub-section for inter- and trans- disciplinary studies.
Translational Vascular Research
Topic Editor: L. Christian Napp
University of Medicine Hannover, Germany
Vascular cell adhesion and differentiation
Topic Editor: Emanuela Barletta
University of Florence School of Human Health Sciences, Italy
Topics of interest include, but are not limited to:
- Molecular and cellular mechanisms of angiogenesis
- Molecular and cellular mechanisms of vascular embryology
- Angiogenesis and cancer
- Angiogenesis and cardiovascular pathology
- Angiogenesis and cerebral stroke
- Angiogenesis and neurodegenerative diseases
- Angiogenesis, tissue regeneration including wound healing and 3 D additive biological manufacturing
- Angiogenesis and inflammation
- Angiogenesis and diabetes mellitus
- Imaging methods and protocols related to vascular system
- Immunohistochemistry related to vascular markers
- Clinical studies related to anti- or pro-angiogenic factors
- Case presentation focusing on a rare vascular entity
All articles published by Vascular Cell are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers.
As an open access journal, Vascular Cell then asks authors to choose one of two Creative Commons licenses, each of which allows readers to reuse the published content in specific ways. The CC BY-NC license allows readers to distribute, adapt, or reuse articles for non-commercial purposes, while commercial reuse requires permission. The CC BY license allows readers to distribute, adapt, or reuse articles, including for commercial purposes.
As authors of articles published in Vascular Cell you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the 'Vascular Cell license agreement'.
Article Processing Charges (APC)
VascularCell is an online-only open access journal supported by article processing charges (APCs).
Effective for new manuscript submissions received on and after January 01, 2017, the base APC for articles published under a CC BY-NC license is 970 USD. The base APC for articles published under a CC BY license is 1,200 USD.
Discounts and surcharges
Significant discounts are available for corresponding authors who are Vascular Cell editors and/or those who are affiliated with institutions that license or subscribe to Vascular Cell journals.
VascularCell published authors receive a 10% discount on APCs.
VascularCell active editors receive a 20% discount on APCs.
All articles published in Vascular Cell are included in:
- PubMed Central